Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents

The Journal of Infectious Diseases
C M BrandtJ M Steckelberg

Abstract

The efficacy of treatment with a combination of ampicillin, imipenem, and vancomycin was compared with that of two-drug combinations or monotherapy in a model of experimental endocarditis using a strain of Enterococcus faecium with high-level resistance to vancomycin and moderate intrinsic resistance to ampicillin and imipenem. In vitro time-kill synergy studies demonstrated bactericidal synergistic activity only for the triple combination. In vivo, monotherapy with vancomycin was not effective. Treatment with either ampicillin or imipenem alone or in combination with vancomycin resulted in <4 log10 reduction in colony-forming units (cfu) per gram of vegetation. The combination of ampicillin with imipenem was highly active (an additional 5 log10 reduction in cfu per gram of vegetation compared with the most active single agent), but efficacy was not increased by the addition of vancomycin to ampicillin and imipenem. Therapy with the combination of ampicillin and imipenem may be effective for some strains of multidrug-resistant enterococcal infections.

Citations

Jul 22, 2004·Current Infectious Disease Reports·Martin E. StryjewskiVance G. Fowler
Jul 10, 2007·Current Infectious Disease Reports·Elias AbrutynG Ralph Corey
Feb 11, 2011·Current Infectious Disease Reports·Subramanian Swaminathan, George J Alangaden
Jun 12, 2013·Current Infectious Disease Reports·Katherine Reyes, Marcus Zervos
Sep 1, 1999·The Journal of Infection·F K Gould
May 22, 2002·Cellular Signalling·Yolanda RománLuis M Botana
May 1, 1997·International Journal of Antimicrobial Agents·L MouthonL Gutmann
Mar 9, 2000·The New England Journal of Medicine·B E Murray
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thuan Le, Arnold S Bayer
Oct 12, 2000·Clinical Microbiology Reviews·Y CetinkayaC G Mayhall
Oct 14, 2008·Expert Review of Anti-infective Therapy·Cesar A Arias, Barbara E Murray
Jun 30, 2015·Future Microbiology·J M PericásJ M Miró
Oct 19, 2012·Virulence·Brian L Hollenbeck, Louis B Rice
May 22, 2016·Infectious Disease Clinics of North America·William R MillerCesar A Arias
Feb 23, 2000·Mayo Clinic Proceedings·A Virk, J M Steckelberg
May 1, 1997·Revista Do Instituto De Medicina Tropical De São Paulo·V Amato Neto, J Pasternak
Sep 17, 2015·Circulation·Larry M BaddourUNKNOWN American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular
May 24, 2019·Current Infectious Disease Reports·German A ContrerasCesar A Arias
Dec 18, 2015·Open Forum Infectious Diseases·Jennifer A JohnsonG Ralph Corey
Feb 4, 1999·Scandinavian Journal of Gastroenterology·R BensoussanM Laverdiere
Mar 12, 2020·ACS Infectious Diseases·Declan Alan Gray, Michaela Wenzel
Sep 24, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel M Musher, Reuben J Arasaratnam
Jun 24, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C A AriasB E Murray

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.